Evaluation of Spironolactone in Combination with Furosemide in Cirrhotic Patients with Permagna (Large) Ascites
Ascites happens in 50% of patients with liver cirrhosis, Some of them experienced permagna ascites (large ascites). Based on the European Association for the Study of the Liver (EASL) guidelines in 2010, therapy of permagna ascites (large ascites) is paracentesis followed by restriction of sodium in...
Saved in:
Main Authors: | Tuty Mulyani (Author), Fita Rahmawati (Author), Neneng Ratnasari (Author) |
---|---|
Format: | Book |
Published: |
Universitas Gadjah Mada,
2017-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Furosemide and spironolactone doses and hyponatremia in patients with heart failure
by: Ivan Velat, et al.
Published: (2020) -
The impact of large-volume paracentesis on renal haemodynamics in cirrhotic patients with ascites
by: Tary Abdel-Hamid Salman, et al.
Published: (2014) -
Impact of continued administration of tolvaptan on cirrhotic patients with ascites
by: Tomomi Kogiso, et al.
Published: (2018) -
Plasma concentration and efficacy of tolvaptan in cirrhotic patients with refractory ascites
by: Eri Sagawa, et al.
Published: (2019) -
Foramina Parietalia Permagna Syndrome
by: J Gordon Millichap
Published: (1998)